Investor Presentaiton slide image

Investor Presentaiton

Appendix 1: Australasian product portfolio AFT has the #1 selling product (Maxigesic) in the Australian para-ibu¹ combo pain relief. AFT's portfolio includes a combination of 125 proprietary, branded and generic products which address the following therapeutic areas: Pain Eyecare Vitamins Allergy Gastrointestinal Maxigesic, ParaOsteo, ZoRub OA/HP, Fenpaed, Combolieve Day/Night PHOUT OF REACH OF CHR maxigesic Y MEDICINE Paracetamol 500mg ibuprofen 180mg DOUBLE ACTION 30 Film Coated Tablets Hylo, Novatears, CromoFresh, Opti-soothe Wipes/Mask, VitAPOS Ferro-liquid, FerroTab, Ferro-F, Ferro-sachets, Lip VitC, CalciTab HYLO- HYLO FORTE FRIGH NOVATEARS EYE DRC Ferro-liquid ferro-sachets fern-tab Terra-1-tab Zo-RubOA ZoRubHP MASSACRETS VITAMIN C LIPO-SACHETS LIPCSHELL Loraclear, Histaclear, Fexaclear, Levoclear, Allersoothe, Lorapaed, Becloclear, Steroclear Gastrosoothe/Forte, LaxTab, Micolette, Nausicalm, Dia Relieve PHARMACY MEDICINE KEEP OUT OF REACH OF CHILDREN gastro soothe Hyoscine Butylbromide Table PHARMACY MEDICINE KEEP OUT OF REACH OF CHILDREN gastro-soothe Hyscine Butybromide FORTE or the relief of stomach ashe PHARMACY MEDICINE KEEP OUT OF REACH OF CHILDREN Histaclear Non-Drowsy Allergy Relief ayerHchy' eyes AFTM nd pain due to cramp or AFT 10 tablets PHARMACY MEDICINE BEEP OUT ON ACH OF CO Loraclear Hayfever Relief Non-drowsy antihistamine for rapid allergy rele AFT cal 30 Tablets Dermatology Crystaderm, Crystawash Hand Sanitizer, Crystasoothe, ZoRub anti-chafing, Decazol, MycoNail, Restora Nail Acne: Cuts Burns School Sores Skin Infections Grazes BSTANSION GRYSTAWAS CRYSTADERM® First Aid Cream Han Rom we Bum Go und Wish S 159 Hospital 1 Paracetamol and Ibuprofen AFT pharmaceuticals Maxigesic IV, Injectables maxigesic/V PRESCRIPTION ONLY MEDICINE KEEP CUT OF REACH OF CHILDREN maxigesiCIV Solutioforsion Paracetamol 1000 ng and buprofanas sadum diydere 300 mg in 100 mL 10x1000000000000 APT axigesic band tupelmadused CRYSTAWASH Sensing Hand G TO HANG PULL HERE Page 21
View entire presentation